reboxetine has been researched along with Raynaud Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoli, R; Girardin, F; Lauterburg, BH; Russmann, S | 1 |
| Clark, DW; Correa-Nunes, AM; Edwards, IR | 1 |
2 other study(ies) available for reboxetine and Raynaud Disease
| Article | Year |
|---|---|
Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.
Topics: Adrenergic Uptake Inhibitors; Adult; Female; Humans; Indoles; Morpholines; Raynaud Disease; Reboxetine; Serotonin Receptor Agonists | 2003 |
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).
Topics: Adrenergic Uptake Inhibitors; Female; Fingers; Humans; Ischemia; Male; Morpholines; Raynaud Disease; Reboxetine | 2003 |